BetterLife Pharma Inc.
BETR
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 440.60K | -1.05M | -1.43M | -964.80K | -143.90K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -419.50K | 223.90K | 1.16M | 418.40K | -293.00K |
| Change in Net Operating Assets | -125.20K | 95.90K | -357.00K | 357.40K | 145.40K |
| Cash from Operations | -104.00K | -731.40K | -633.00K | -189.00K | -291.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 0.00 | 1.22M | 300.00K | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 34.40K | 705.00K | -- | -- | 427.40K |
| Repurchase of Common Stock | -- | -- | -- | -100.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 20.20K | -- | -- |
| Cash from Financing | 25.20K | 514.90K | 917.10K | 148.10K | 314.70K |
| Foreign Exchange rate Adjustments | 0.00 | 0.00 | 0.00 | -100.00 | 100.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -78.80K | -216.60K | 284.10K | -40.90K | 23.30K |
